Skip to main content
Clinical Trials/JPRN-UMIN000015217
JPRN-UMIN000015217Recruiting未知

Identification of Antibodies Involved in Atherosclerosis Progression and Evaluation of Orencia`s Efficacy on Antibodies, Atherosclerosis Biomarkers and Structural Markers in Orencia-Treated Patients with Rheumatoid Arthritis Complicated by Atherosclerosis - Orencia Atherosclerosis And Rheumatoid Arthritis Study (ORACLE Arthritis Study)

Yokohama City University Graduate School of Medicine0 sites40 target enrollmentStarted: October 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion criteria are as follows: 1.Patients in whom Orencia is contraindicated such as patients with a history of hypersensitivity to any ingredient of Orencia 2.Patients with active infection or malignancies 3.Patients who have been treated with other biological products or molecular targeted drug therapy 4.Pregnant women, lactating women, and patients who wish to become pregnant 5.Patients who have not provided consent to participate in the study 6. Patients who doctor considered inappropriate for study enrollment.

Investigators

Sponsor
Yokohama City University Graduate School of Medicine

Similar Trials